Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4703729

Cl.N[C@@H](CCCl)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2385511 1.00
SCHEMBL2544716 0.97
SCHEMBL28848838 0.97
SCHEMBL30918327 0.97
Hydrochloric Acid SCHEMBL11434603 0.83 GSR (0.61)
Hydrochloric Acid SCHEMBL11780148 0.83 GSR (0.65)
SCHEMBL29268469 0.82
SCHEMBL5287112 0.80 GSR (0.64)
SCHEMBL602426 0.80 GSR (0.68)
SCHEMBL8068164 0.80 GSR (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121758308-B Preparation method of L-2, 4-diaminobutyric acid dihydrochloride 山东省农药科学研究院 2026-05-19 CN claimed
CN-119735517-A Process for the continuous flow preparation of (S) -4-chloro-2-aminobutyrate hydrochloride 利尔化学股份有限公司 2025-04-01 CN claimed
CN-116655484-B Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride 佳木斯黑龙农药有限公司 2024-02-13 CN claimed
CN-116655484-A Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride 佳木斯黑龙农药有限公司 2023-08-29 CN claimed
CN-116171270-A Preparation method of (S) -4-chloro-2-aminobutyric acid hydrochloride and (S) -4-chloro-2-aminobutyric acid ester 利尔化学股份有限公司 2023-05-26 CN claimed
CN-115583967-A Preparation method of refined glufosinate-ammonium 佳木斯黑龙农药有限公司 2023-01-10 CN claimed
CN-121758308-B Preparation method of L-2, 4-diaminobutyric acid dihydrochloride 山东省农药科学研究院 2026-05-19 CN disclosed
CN-119735517-A Process for the continuous flow preparation of (S) -4-chloro-2-aminobutyrate hydrochloride 利尔化学股份有限公司 2025-04-01 CN disclosed
CN-119735517-A Process for the continuous flow preparation of (S) -4-chloro-2-aminobutyrate hydrochloride 利尔化学股份有限公司 2025-04-01 CN disclosed
CN-119735517-A Process for the continuous flow preparation of (S) -4-chloro-2-aminobutyrate hydrochloride 利尔化学股份有限公司 2025-04-01 CN disclosed
CN-116655484-B Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride 佳木斯黑龙农药有限公司 2024-02-13 CN disclosed
CN-116655484-B Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride 佳木斯黑龙农药有限公司 2024-02-13 CN disclosed
CN-116655484-A Preparation method of L-4-chloro-2-aminobutyric acid ester hydrochloride 佳木斯黑龙农药有限公司 2023-08-29 CN disclosed
CN-116171270-A Preparation method of (S) -4-chloro-2-aminobutyric acid hydrochloride and (S) -4-chloro-2-aminobutyric acid ester 利尔化学股份有限公司 2023-05-26 CN disclosed
WO-2023051768-A1 METHODS FOR PREPARING (S)-4-CHLORO-2-AMINOBUTYRIC ACID HYDROCHLORIDE AND (S)-4-CHLORO-2-AMINOBUTYRATE 利尔化学股份有限公司 2023-04-06 WO disclosed
CN-115583967-A Preparation method of refined glufosinate-ammonium 佳木斯黑龙农药有限公司 2023-01-10 CN disclosed
EP-1567489-B1 PYRROLIDIN-2-ONE DERIVATIVES AS INHIBITORS OF THROMBIN AND FACTOR XA GLAXO GROUP LTD (GB) 2008-07-23 EP disclosed
US-20060166985-A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa GLAXO GROUP LIMITED (GB) 2006-07-27 US disclosed
EP-1567489-A1 PYRROLIDIN-2-ONE DERIVATIVES AS INHIBITORS OF THROMBIN AND FACTOR XA GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004052851-A1 PYRROLYDIN-2-ONE DERIVATIVES AS INHIBITORS OF THROMBIN AND FACTOR XA GLAXO GROUP LIMITED (GB) 2004-06-24 WO disclosed